WHO To Move On Internet Drug Trade

6 April 1997

At its annual meeting in May in Geneva, the World Health Organizationwill consider a draft resolution calling for countermeasures to curb the potentially dangerous trade in pharmaceuticals over the Internet.

The draft is now being drawn up by officials of various governments concerned over the widening phenomenon through the global computer network, sources told the Kyodo News Service, with Belgium taking the lead.

The draft resolution calls for the WHO secretariat to survey the current situation, set up a special working group to consider policy responses and define a set of conclusions by next January. Problems involve dangerous drugs being sold without a prescription, drugs past their expiry date being sold to developing countries, and drugs from countries not requiring prescriptions being sold to countries which do require them.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight